Gamida Cell has completed patient recruitment for its StemEx trial #regenerativemedicine

Just over a month ago I blogged about Gamida Cell's pivotal trial for their flagship product, StemEx®. Today I received news from Yael Margolin, CEO, Gamida Cell that the pivotal trial has completed its patient recruitment and clinical data is expected in Q4 of 2012. In the lead up to the World Stem Cell & Regenerative Medicine Congress, we are …